To examine whether CD51+ PCa subpopulations display overlapping expression with other proven prostate CSC markers, we performed dual-color flow cytometric analysis for CD44 and CD51 in PCa cell lines. This evidence concerns the gene CD44 and posterior cortical atrophy.